5-carboxyfluorescein diacetate has been researched along with acarbose in 1 studies
Studies (5-carboxyfluorescein diacetate) | Trials (5-carboxyfluorescein diacetate) | Recent Studies (post-2010) (5-carboxyfluorescein diacetate) | Studies (acarbose) | Trials (acarbose) | Recent Studies (post-2010) (acarbose) |
---|---|---|---|---|---|
41 | 0 | 13 | 118 | 0 | 86 |
Protein | Taxonomy | 5-carboxyfluorescein diacetate (IC50) | acarbose (IC50) |
---|---|---|---|
Chain A, Cyclomaltodextrin glucanotransferase | Bacillus sp. 1011 | 5600 | |
Alpha-amylase 1A | Homo sapiens (human) | 0.748 | |
Lysosomal alpha-glucosidase | Homo sapiens (human) | 5 | |
Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | 1.97 | |
Lysosomal alpha-glucosidase | Rattus norvegicus (Norway rat) | 1.3892 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
1 other study(ies) available for 5-carboxyfluorescein diacetate and acarbose
Article | Year |
---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |